Tf has been conjugated to cytotoxic agents (e.g., diphtheria toxin, ricin and gelonin) to study their ability to target these toxins to tumor cells, while reducing their non-specific toxic effects on non-tumor cells [81]. The gene discussed is TF; the disease is neoplasm.